W

Wagner Macula & Retina Center | Norfolk, VA

Research site
(Unclaimed)
Location
6160 Kempsville Circle, Norfolk, Virginia, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 16
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

The objective is to evaluate the safety and efficacy of low dose and high dose CBT-001 eye drop dosed twice daily for 24 months compared to vehicle i...

Enrolling
Pterygium
Drug: Vehicle
Drug: CBT-001

This main long-term extension study is designed to evaluate the long-term safety and tolerability of faricimab 6 milligrams (mg) administered by intr...

Active, not recruiting
Neovascular Age-related Macular Degeneration
Other: Sham Procedure
Drug: Faricimab

RGX-314 is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD). Wet AM...

Enrolling
Wet Age-related Macular Degeneration
WetAMD
Genetic: RGX-314 Dose 2
Biological: Aflibercept (EYLEA®)

Trial conditions

Macular Degeneration (8 trials)
Edema (4 trials)
Macular Edema (4 trials)
Atrophy (3 trials)
Geographic Atrophy (3 trials)
Wet Macular Degeneration (3 trials)
Diabetic Retinopathy (1 trial)
Pterygium (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems